166 related articles for article (PubMed ID: 15195503)
1. The prognostic value of serum inhibin, 17 beta-estradiol and progesterone in cases of hydatidiform mole.
Hegab HM; Schindler AE
Gynecol Endocrinol; 2004 Feb; 18(2):107-13. PubMed ID: 15195503
[TBL] [Abstract][Full Text] [Related]
2. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
[TBL] [Abstract][Full Text] [Related]
3. Inhibin: a new circulating marker of hydatidiform mole?
Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
[TBL] [Abstract][Full Text] [Related]
4. Circulating inhibin forms in patients with hydatidiform mole.
Kato T; Seki K; Matsui H; Sekiya S
Gynecol Obstet Invest; 2002; 54(2):114-7. PubMed ID: 12566755
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
7. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
8. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
Ho PC; Wong LC; Ma HK
Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
10. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
11. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of serum human chorionic gonadotropin ratio, progesterone and inhibin A for expectant management of early pregnancies of unknown location.
Majeed H; Højgaard A; Johannesen P; Ladefoged ML; Forman A; Bor P
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):66-9. PubMed ID: 22921576
[TBL] [Abstract][Full Text] [Related]
13. Serum activin A and inhibin A. New clinical markers for hydatidiform mole.
Florio P; Severi FM; Cobellis L; Danero S; Bomè A; Luisi S; Petraglia F
Cancer; 2002 May; 94(10):2618-22. PubMed ID: 12173329
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
[TBL] [Abstract][Full Text] [Related]
15. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
16. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
[TBL] [Abstract][Full Text] [Related]
17. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
Dawood MY
Acta Endocrinol (Copenh); 1975 Aug; 79(4):729-39. PubMed ID: 169657
[TBL] [Abstract][Full Text] [Related]
18. Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?
Pautier P; Ghione S; Brailly-Tabard S; Lhommé C; Morice P; Bidart JM
Hum Reprod; 2001 Nov; 16(11):2434-7. PubMed ID: 11679534
[TBL] [Abstract][Full Text] [Related]
19. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
[TBL] [Abstract][Full Text] [Related]
20. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
